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ABSTRACT (300/300) 
 
Background: Obstructive sleep apnea (OSA) is a chronic, multisystem disorder that has a bidirectional 
relationship with several major neurological disorders, including Alzheimer’s dementia.  Treatment with 
Continuous Positive Airway Pressure (CPAP) offers some protection from the effects of OSA, although it is 
still unclear which populations should be targeted, for how long, and what the effects of treatment are on 
different organ systems. We investigated whether cognitive improvements can be achieved as early as one 
month into CPAP treatment in patients with OSA. 
Methods: 55 patients (mean (SD) age: 47·6 (11·1) years) with newly diagnosed moderate-severe OSA 
(Oxygen Desaturation Index: 36·6 (25·2) events/hour; Epworth Sleepiness Score (ESS): 12·8 (4·9)) and 35 
matched healthy volunteers were studied. All participants underwent neurocognitive testing, neuroimaging 
and polysomnography. Patients were randomised into parallel groups: CPAP with best supportive care 
(BSC), or BSC alone for one month, after which they were re-tested.  
Findings: One month of CPAP with BSC resulted in a hypertrophic trend in the right thalamus [mean 
difference (%): 4·04, 95%CI 1·47 to 6·61], which was absent in the BSC group [-2·29, 95%CI -4·34 to -
0·24].  Significant improvement was also recorded in ESS, in the CPAP plus BSC group, following 
treatment [mean difference(%): -27·97, 95%CI -36·75 to -19·19 vs 2.46 95%CI -5·23 to 10·15; P=0·012], 
correlated to neuroplastic changes in brainstem (r=-0·37; P=0·05), and improvements in delayed logical 
memory scores [57·20, 95%CI 42·94 to 71·46 vs 23·41 95%CI 17·17 to 29·65; P=0·037].  
Interpretation: One month of CPAP treatment can lead to adaptive alterations in the neurocognitive 
architecture that underlies the reduced sleepiness, and improved verbal episodic memory in patients with 
OSA. We propose that partial neural recovery occurs during short periods of treatment with CPAP. 
 
Funding: Wellcome Trust [103952/Z/14/Z] and NIHR Respiratory and Cardiac Biomedical Research Units, 
at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The funders had 
no role in study design, data collection, data analysis, interpretation or writing of the report. 
 
Key words: Obstructive sleep apnoea, Continuous Positive Airway Pressure, Neuroimaging, Cognition. 
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INTRODUCTION 
Obstructive sleep apnoea (OSA) is a debilitating, chronic multisystem sleep disorder that arises from 
recurrent partial or complete pharyngeal obstruction during sleep.1, 2 It has been proposed to have an 
important, if not fully understood, bidirectional relationship with several major neurological disorders. 1, 3, 4 A 
close association of OSA with early onset of cognitive decline, by as much as a decade, has been reported, 
whilst a growing body of clinical and animal work advocates that OSA should be recognized as one of rare 
modifiable risks for Alzheimer’s dementia.3, 5, 6  In addition, treatment with Continuous Positive Airway 
Pressure (CPAP), the main treatment for OSA, has been also variably shown to halt the onset, decelerate 
the progression, or offer a better prognosis in patients with co-morbid dementia, epilepsy and stroke.5-9 
Numerous clinical studies over the years have demonstrated changes in the central nervous system (CNS) 
of patients with OSA, including altered resting cerebral blood flow pattern10 with hypoperfusion during the 
awake states11, changes in the electroencephalogram (EEG) and aberrant cortical excitability12-14 and 
changes in both white and grey matter.15-19 These studies have largely also suggested a putative 
neurocircuitry fingerprint at which core lies the disconnection of the frontal regions20 and the disruption of 
the (cerebello)-thalamocortical oscillator with involvement of the hippocampal formation.4, 16, 21, 22 
The additive impact of progressive changes in sleep quality and structure, changes in cerebral blood flow, 
neurovascular and neurotransmitters, plus the cellular redox status are all likely to contribute to the 
cognitive deficits reported in up to one out of four newly diagnosed OSA patients.3, 23, 24 Despite concerted 
efforts, OSA remains widely underdiagnosed in the general population, with its prevalence predicted to 
increase sharply over the coming years due to the epidemics of ageing and obesity.1, 25 The important 
questions of what, who and when to treat, are far from clear.3, 26, 27 Persistent deficits, even after prolonged 
treatment with CPAP in some patients, suggest that early detection of the central nervous system (CNS) 
sequelae in OSA could be crucial.3, 28, 29 
In a recent study of patients with OSA, augmentation of subjective experience, attention and vigilance has 
been demonstrated after only one night of CPAP.26 However, no appreciative impact on procedural memory 
consolidation was noted, suggesting differential impact on brain structures underlying these processes.26  
On the other hand, in a seminal study, three months of CPAP treatment led to a significant recovery of 
cognitive and morphometric deficits.30  Taken together, empirical clinical experience and early research 
findings suggest that subjective memory improvements are reported as early as one month following the 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
4 
 
commencement of CPAP treatment.9 In the present study, we set out to investigate this timeframe, testing 
the hypothesis that one month of CPAP treatment would lead to cognitive improvements, and that any 
changes would be associated with neuroplastic changes in patients with OSA.  
 
METHODS 
Participants and Design 
Patients with newly diagnosed OSA (18-65 years old) were recruited from Royal Brompton and Harefield 
Hospitals’ sleep clinics. Inclusion criterion was an apnea/hypopnea index (AHI) >10 events/h.31 Apneas 
were defined as >80% drop in airflow for 10s. Hypopneas were defined as >50% reduction in airflow from 
baseline with a >4% dip in saturation, or an arousal from sleep.32-34 Exclusion criteria were a history of 
respiratory, cerebrovascular and/or ischemic heart disease, diabetes mellitus, neuropsychiatric or 
neurological disorder, alcohol, drug abuse, or psychoactive medications.  
The same exclusion criteria were used for healthy controls (age- and education-matched) recruited from a 
database of healthy volunteers. Those with a history of sleep problems on questionnaires, or evidence of 
OSA on pulse-oximetry (ODI >5 events/h) were excluded.  
All enrolled patients were randomly allocated [stratified by age, OSA severity (oxygen desaturation index 
(ODI) & AHI) and years of education], by an independent study coordinator, to receive CPAP with best 
supportive care (BSC), or BSC alone, for one month and then re-assessed (Figure 1). 
The study was part of ongoing research to investigate the impact of OSA on the brain and was approved by 
the UK central research ethics committee (10/H0706/51). All patients gave written informed consent.  
Intervention 
CPAP treatment was initiated using standard clinical practice at each centre (ResMed S9; with 
humidification as required).  
BSC comprised of advice on minimising daytime sleepiness through sleep hygiene, naps, caffeine, 
exercise and weight loss as appropriate to each patient. Both groups were provided with BSC and asked to 
continue with their usual medical care during the trial.  
Assessments 
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Structured assessments were performed at baseline (patients and controls) and at follow-up after one 
month (patients only). In addition, all patients received a telephone call at 1 week to record symptoms, side-
effects, and to optimise CPAP adherence. All OSA patients completed an inpatient polysomnography 
(SOMNOscreen PSG, S-Med, UK) prior to CPAP initiation. Domiciliary overnight pulse-oximetry (Konica-
Minolta Inc,) was performed at one month. Treatment compliance was measured objectively by download 
of the CPAP smart card at the one-month visit. 
Cognitive Tests Battery 
Cognitive function of all participants was assessed using a battery of tests comprising the Addenbrooke’s 
Cognitive Examination-Revised (ACE-R)35, 36, Trail Making Test A and B37 (TMA, TMB), Logical Memory 
(LM) Test: immediate and delayed LM with alternate stories used at baseline and follow up, subtests from 
the Wechsler Memory Scales38, Digit Span Test: forward (DSF) and backward (DSB)38, Spatial Span 
subtest  forward (SSF) and backward (SSB) (the visual-spatial version of Digit Span)39. The tests used 
were chosen to target cognitive domains that have been previously shown to be affected by OSA by our 
and other groups. 3, 40  
ACE-R is a brief battery that provides evaluation of six cognitive domains (orientation, attention, memory, 
verbal fluency, language and visuospatial ability).35 It is useful for detecting dementia and mild cognitive 
impairment, and it is able to distinguish between patients with progressive degenerative disorders and 
those with affective disorders.41 The total score is 100, higher scores indicate better cognitive functioning, 
each domain has individual scores and there are age and education dependent norms for the total score as 
well as for the individual domains.35 The subscores for the domain of verbal fluency (ACE-R verbal fluency) 
were used in this study to asses both executive and language abilities.42  
The TMT consists of two parts, A and B; it is one of the most widely used neuropsychological tests that 
provides information on visual conceptual and visuomotor tracking, motor speed, attention and executive 
functions.37 It is a timed test and the score represents the amount of time required to complete the task.37 
Performance decreases with increasing age and lower levels of education although normative data is 
available.43 
Wechsler Adult Intelligence Scale, third edition (WAIS-III)39 is a commonly used commercially available 
validated assessment of cognitive function. The LM, DSF, DSB, SSF and SSB tests used in our study were 
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subtests of the (WAIS-III) and administered and scored as recommended by the WAIS-III instruction 
manual.39 LM tests the patient’s ability to remember two short stories presented orally.39 There is an 
immediate test and then a delayed recall test after 30 minutes; it is a measure of verbal memory. Digit Span 
task is used to measure working-memory's number storage capacity.39 Participants are presented with a 
series of digits and must repeat them back. The length of the longest list a person can remember is that 
person's digit span. While the participant is asked to enter the digits in the given order in the forward digit-
span task, in the backward digit-span task the participant needs to reverse the order of the numbers.39 
Spatial Span Forward and Backwards is a measure of visual-spatial processing and working memory.39 It is 
validated in older patients as cognitive impairment severity increases there is a reduction in the total score. 
The spatial span backwards is a more sensitive measure of early cognitive impairment as opposed to the 
spatial span forward which remains relatively stable regardless of the level of impairment.44 Spatial Span 
forward is an attention task, whereas spatial span backward is considered a working memory task as it 
requires holding information in the memory.39 
Magnetic Resonance Imaging  
All participants underwent MR imaging and T1-weighted MR-images were acquired using a 1.5T scanner 
(Magnetom Vision, Siemens Healthcare, Camberley, Surrey, UK) and a 3D MP-RAGE sequence (TI 
300ms, TE 4ms, in-plane resolution 1·0x1·0mm) with contiguous 2mm coronal slices. The T1-weighted 
images were processed, and volumetry was performed using the automated method FreeSurfer, as 
previously described by our group.33  
Statistical Analyses 
The Kolmogorov-Smirnov test was used to test the normality of distributions. To analyse differences in a 
variety of demographic parameters between healthy controls and OSA patients, Student’s t-test was 
applied (Table 1). All statistical analyses had a 2-tailed α level of <05 for defining significance and were 
performed by a biostatistician on the statistical software “STATISTICA 10·0” (http://www.statsoft.com). 
Investigation of a priori hypotheses was focused on group differences for several neuroanatomical 
structures that had been previously highlighted by our data and that of other groups, to present network 
hubs of OSA-affected neurocircuitry: the hippocampus, amygdala, basal ganglia, thalamus, brainstem, 
corpus callosum (and its subdivisions) and cerebellum.3, 45 In addition, several previously reported affected 
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cognitive domains were assessed.40 The intracranial volume (ICV) calculated by FreeSurfer did not differ 
significantly between groups (t-test, P=·514) and student’s t-test was done on the ICV normalised data (i.e. 
volume/ICV) to assess between-group differences (Supplement Table S2). Hierarchical cluster analysis 
(HCA)46 was further undertaken to identify homogeneous groups of variables amongst differential (diff ∆) 
changes in brain volumes following the two interventions. HCA results in the formation of clusters in which 
profiles are iteratively joined in a descending order of similarity. More specifically, in our study, the 
agglomerative hierarchical clustering algorithm was used that started with each variable in a separate 
cluster and combined clusters until only one was left. The resulting cluster hierarchies were displayed as 
tree diagrams, i.e. dendrograms (Figure 2). The clustering method was used to show between-groups 
linkage with squared Euclidean distance as a measure of distance. The final number of clusters has been 
defined according to highest coefficient changes in agglomeration schedules. Statistical analysis for HCA 
was performed with IBM SPSS Statistics version 21.0 (http://www01.ibm.com/software/analytics/spss/).  
During post-hoc analyses interregional connectivity and inter-domain relationships between the right 
thalami, somnolence (ESS test scores) and verbal episodic memory (delayed LM test scores) were 
explored with Pearson correlations; controlled for ICV and normalised for differential changes (diff ∆%) from 
the baseline ( diff∆ =[V/domainpre -V/domainpost]/V/domain pre x100). All results were Bonferroni corrected for 
multiple comparisons.  Finally, partial correlations47 were used to control for the body mass index (BMI) 
confounding effect on correlation coefficients between neuroimaging and cognitive tests’ scores changes.  
 
RESULTS 
Fifty five OSA patients (81%) completed the study, in addition to 35 age- and education- matched healthy 
volunteers (Figure 1). Attrition was due to incomplete investigations in 10% (7/68) of the BSC group, and 
9% (6/68) of the CPAP group. Mean (SD) age of OSA patients was 47·6(11·1) years, ODI 36·6 (25·2) 
events/hour, and ESS 12·8(4·9). Baseline demographic characteristics of participants are shown in Table 1. 
Baseline sleep characteristics are shown in Supplement Table S1. The baseline characteristics were 
similar between the CPAP with BSC group and BSC only group. Median CPAP use over one month was 
5·0 (range 1·9-6·9) hours/night (Table 1). 
A Priori Hypotheses Investigations  
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At baseline, hypotrophic changes were recorded in the left hippocampus, in the bilateral pallidus and the 
mid-posterior part of the corpus callosum of OSA patients (n=55) in comparison to those recorded in 
healthy controls (n=35) (Figure 3: pre-CPAP). Following one month of interventions, the between-group 
comparison (patient groups vs healthy controls) no longer showed statistically significant hypotrophic 
changes in either of these structures, suggesting that adaptive neuroplastic changes have occurred 
(Supplement Table S2). The hierarchical cluster analysis further demonstrated the distinct alteration pattern 
for each intervention during this period (Figure 2), with the thalamic alterations in the CPAP group closely 
linked to wider core neurocircuitry adaptations, compared to the BSC group.   
The differential neuroanatomical structural changes at one month between the CPAP group and the BSC 
group were subsequently explored.  In the CPAP group, a significant hypertrophic trend (Figure 3) for the 
right thalamus was recorded [mean diff∆%(SD):CPAP, 4·04(13·61) vs BSC, -2·29(10·66); P=0·06]. No other 
statistically significant differences between groups were found (Supplement Table S3). 
At baseline, OSA patients showed significantly impaired cognitive processing in several domains by 
comparison to healthy controls (Table 2). Following one of month of interventions, improvement was 
recorded in the majority of tested domains compared to healthy controls (Table 2). However, comparison of 
differential cognitive changes between interventions, suggested that only changes in sleepiness [mean 
diff∆%(SD): CPAP, 2.46(39·97) vs BSC, -27·97(46·46); P=0·012] and verbal episodic memory test scores 
[23·41(32·45)vs57·20(75·46); P=0·037] were statistically significant (Supplement Table S4).  
In summary, the findings of a priori between-interventions analyses demonstrated the differential 
neuroplastic cognitive and morphometric adaptations already after one month of treatment (Figure 2, 3; 
Supplement Tables S3, 4). 
Post hoc (Secondary) Analyses  
Secondary correlational analyses were dictated by the three significant findings of a priori investigations. 
We explored the pathomechanisms behind improvements in episodic memory, somnolence and the 
hypertrophic trend for the thalamus in the CPAP group (Figures 3 & 4). Significant correlation between 
improvement in sleepiness and volumetric changes in the brainstem (r= -0·37; P=0·05) was found (Figure 
4), whilst improvements in verbal episodic memory were not obviously correlated to any singular 
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morphometric change. Similarly, hypertrophic changes in the right thalamus appeared strongly correlated to 
changes in bilateral cortical cerebellar (CC) and hippocampal (H) structures (left CC r= 0·77;P=1·96 10-6; 
right CC r= 0·75;P= 3·78 10-6; left H r= 0·49;P<0·01; right H r= 0·51;P<0·01), which was not the case for 
OSA patients that received only BSC intervention. In the CPAP group, thalamic changes were also found to 
be correlated with changes in overall cognitive functioning (ACE-R) scores (r=-0·554; P=0·002), attentional 
span changes (DSF, r=-0·499; P=0·007) and with changes in visuospatial working memory (SSB, r=-0·370; 
P=0·05). 
Positive correlations between improvements in scores of verbal episodic memory and semantic subdomain 
of verbal fluency (fluency ACE-R) (r=0·406; P=0·032) that were otherwise negatively correlated in the BSC 
group (r=-0·190, P=0·343), were also shown. 
Episodic memory showed significant positive correlation with span changes in the CPAP (r=0·451, P=0·02) 
vs BSC group(r=-0·081, P=0·69). ESS scores were not significantly correlated to changes in working 
memory in the CPAP (r=0·295, P=0·127), although they were significant in the BSC group (r=0·591, 
P=0·001).  The correlations between noted changes over one month and ODI values of patients have been 
further explored; here, a significant correlation between changes in the anterior part of corpus callosum and 
ODI (r=0·420; P=0·026) was suggested for the CPAP treated group. Of note is that when variations in 
pattern of alterations were controlled for BMI values, significant impact was noted in the CPAP group on 
decreased association of changes between right thalamic plasticity and verbal fluency scores (r=-0·554 vs 
r=-0·345).  The results of other neuroplastic adaptations and corresponding changes in cognitive domains 
are summarised in Supplement Table S5. 
 
DISCUSSION  
Our findings demonstrate that just one month of CPAP treatment, combined with psychoeducation and 
lifestyle modifications, can redress several cognitive and morphometric deficits in patients with moderate-
severe OSA (defined with an AHI>10 events/hour). These data are consistent with the recovery of grey 
matter regions and cognition in patients with OSA reported by Canessa and colleagues (2011) to occur 
following three months of CPAP treatment.30 Moreover, the same group has recently shown that 
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appreciable recovery of cognition and white matter, including that in corpus callosum, occurs over the 
course of 12-month treatment with CPAP.28 Our study is, to the best of our knowledge, the first time these 
findings have been replicated in much shorter timeframe.45 
The baseline neuroanatomical and neurocognitive impairments recorded in OSA patients were comparable 
to previously reported neurocognitive deficits6, 17,29, 48 and involved the neurocircuitry hubs formerly shown 
as specifically vulnerable to chronic sleep fragmentation and associated nocturnal cycles of intermittent 
hypoxia in clinical and preclinical studies.3, 6, 21, 33, 45 Specifically, hypotrophic changes in regions 
corresponding to hippocampal formation, basal ganglia and parts of corpus callosum were suggested by 
the neuroimaging investigations (Figure 3). Similarly, we recorded excessive daytime somnolence and 
significant impairments in cognitive domains of attention, working memory, verbal episodic memory and 
semantic memory in our OSA patients at baseline (Table 2). 
Of note is that a minimal improvement, both in cognitive and neuroanatomical measures, was 
demonstrated in the OSA patients randomized to BSC over one month (Table 2, Supplement Table S3). 
Similar improvement in patients with OSA has been previously associated with the improved sleep quality 
and argued by the beneficial impact of diet, exercise, lifestyle modifications and psychoeducation.49  In 
addition to any intervention effects or natural neuro homeostatic fluctuations, it is also possible that some of 
the cognitive changes may have represented practice effects.  
In order to distinguish the beneficial impact of CPAP from that of any other interventional modality, the 
between-groups comparison of normalized changes was performed. Consequently, three major constructs 
were highlighted. Specifically, neuroplastic hypertrophic changes in thalamus, decreased daytime 
somnolence and improvements in verbal episodic memory were shown as more likely to result from 
adaptive processes driven by treatment with CPAP, and as such merit further discussion. 
Excessive Daytime Somnolence  
Somnolence is a major complaint in OSA, and whilst its exact neurological substrate is incompletely 
understood,50 it is likely that chronic low-level neuroinflammation affects brain structures that participate in 
the initiation and maintenance of sleep and alertness.3 In agreement with this notion, improvement in 
daytime somnolence following one month of treatment with CPAP was significantly correlated with 
neuroplastic alterations in brainstem (Figure 4) in our study. In addition, brainstem alterations were 
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associated with hypertrophic thalamic changes, which were in turn closely correlated with alterations in 
bilateral cerebellar cortices and hippocampus (Figures 2 & 4). The neuroplastic stream of these 
associations correlated closely with changes in scores of tests of attentional regulation and working 
memory capacity (Figure 5). 
We propose that our findings represent changes in consciousness and arousal regulation that can occur 
within one month, perhaps primarily driven by increased activity/plasticity of brainstem pathways. Many of 
these pathways are known to underlie rapidly generated brief shifts of arousal at times of increased 
cognitive and corticothalamic demand.51 It follows that our findings might also suggest specific vulnerability 
of a thalamocortical oscillator to sleep fragmentation and nocturnal cycles of intermittent hypoxia, 
something that has been long suggested by neurophysiological and neuroimaging data in OSA.21,33 In 
cases of a faulty oscillator, distributed network activity and associated memory may suffer across long-
range cortico–cortical pathways, and within cortico–striatopallidal–thalamocortical loop volleys.51 
It is notable that our findings also show that, whilst in untreated OSA patients changes in scores of tests of 
attention and working memory capacity were strongly affected by severity of their sleepiness, this 
significant association was all but negated by the effects of treatment with CPAP over one month (Figure 
5). As patients with OSA have been shown to be more likely to experience a driving-related traffic accident, 
and given that such accidents have been shown as more likely in those who manifest greater daytime 
sleepiness, we argue that this finding implies strong clinical rationale for CPAP treatment even for a short 
duration.2, 3, 45  
Thalamocortical Circuitry in OSA 
As already suggested, recruitment of central thalamic neurons via the brainstem occurs in response to 
increasing cognitive demand, stress and fatigue that reduce behavioral performance.51 Through thalamic 
activation, neurons across the cerebral cortex and striatum can be depolarized, and their activity selectively 
gated by descending or ascending signals related to premotor attention and alerting stimuli.51 
We and others have argued that in OSA, direct injury to the thalamocortical neurons, or their prominent 
deafferentation as a result of multifocal, neuroinflammatory brain processes, could lead to severe 
impairment of prefrontal functional integration and arousal regulation.21, 51-53 In keeping with this suggestion, 
we speculate that our findings show neuroplastic compensatory thalamic changes, instigated by one month 
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of CPAP treatment, leading to a wider circuitry reorganization involving brainstem, cerebellum and 
hippocampal connectivity (Figures 2, 4). We also propose that CPAP-driven adaptive processes further 
optimize activation of the thalamic system that acts as functional interface between arousal and attentional 
regulation.53, 54 This might then underlie positive subjective experience of decreased mental effort required 
in order to solve tasks following the CPAP treatment. It should be noted that the results of our partial 
correlation analysis (Supplement Table S5) suggest BMI might act as a confounder in noted executive and 
language gains. This potential association between BMI and cognition is not a new proposition, and results 
from a recent prospective controlled trial of eighty patients with mild cognitive impairment suggest strong 
link between BMI decrease and improvements in verbal memory, verbal fluency and executive function.55 
Neurocognitive Architecture of Working and Episodic Memory in OSA 
One month of CPAP treatment resulted in a partial recovery of episodic and working-memory capacity. A 
crucial role for working memory in temporary information processing and guidance of complex behavior, as 
well as its impairment in OSA40, has been recognized.54 There is emerging consensus that working-memory 
maintenance results from the interactions among associative memory representations and basic 
processes, including attention, that are instantiated as reentrant loops between frontal and posterior cortical 
areas, as well as subcortical structures.52, 54 In our study, over one month, wider reorganization in a 
distributed memory system for associative learning occurred, e.g. thalamocortical changes were associated 
with changes in bilateral hippocampi and cerebellar cortices. None of these alterations were observed in 
the BSC group (Figures 4, 5). 
It is of further interest that the hippocampus, the structure most frequently reported affected by 
neuroimaging in OSA,3, 33 has recently been proposed to act as a major shared substrate for working and 
episodic memory.54 Axmacher and colleagues (2015) have suggested that the hippocampus plays a role in 
working-memory maintenance of multiple items by neural assemblies synchronized in the gamma 
frequency range, locked to consecutive phase ranges of oscillatory activity in the hippocampal theta 
range.56 Of note, a decrease in theta band has been shown to occur after apnoea and hypopnoea events in 
some patients with OSA, and CPAP has been shown to normalise EEG changes.4  
Several limitations should be considered when interpreting the findings of this study; the cross-sectional 
design, the absence of follow up of healthy controls and strict exclusion criteria used disallow conclusions 
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to be made regarding causality or interactions between OSA, its treatment, and various comorbidities such 
as hypertension and diabetes. Also, one cannot infer which, if any, interventional aspects of the lifestyle 
modifications and psychoeducation, might have contributed to observed changes.  Furthermore, 
correlations between changes in regional volumes and neuropsychological scores were exploratory and 
hypothesis-generating. Their interpretation of presumed complex and diverse causalities remains a 
challenging issue for the future. Nonetheless, we suggest that our findings indicate an important clinical 
message about the benefits of CPAP treatment. 
The results of this study show that one month of CPAP treatment provides a sufficient timeframe for 
rudimentary neuroplastic changes to occur within targeted brain structures of patients with moderate to 
severe OSA. We also speculate that the structural changes provide a basic neurocognitive architectural 
scaffold for further reorganization, which underlies some of the observed functional recovery in working and 
episodic memory. 
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HIGHLIGHTS (<125 characters with spaces) 
 One month of CPAP treatment leads to adaptive alterations in the neuroanatomy and 
neurocognition in patients with OSA. 
 Improvements in sleepiness and verbal episodic memory were demonstrable following only one 
month of treatment with CPAP. 
 Our findings support the clinical rationale for the use of CPAP treatment to relieve sleepiness, even 
for a short duration. 
  
Research in Context (90/100) 
Obstructive sleep apnea (OSA) is highly prevalent sleep disorder that has been linked with dementia, stroke and 
increased risks of cardiovascular disease. Continuous positive airway pressure (CPAP) treatment has been shown to 
be effective in reducing sleepiness in moderate to severe OSA. However, the evidence for its use to reverse or slow 
the rate of cognitive decline is unclear. Our findings show that one month of CPAP treatment in patients with moderate 
to severe OSA leads to adaptive alterations in the brain networks associated with reduced sleepiness and improved 
memory.  
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Figure legends: 
 
Figure 1: CONSORT diagram. 
Figure 2: Dendrograms depict relationships between structural changes in brain volumes following 
one month of intervention with the Continuous Positive Airway Pressure or Best Supportive Care 
treatment. Dendrograms were constructed using the results of Hierarchical Cluster Analysis (HCA) of the 
differential ∆ structural changes, using Average Linkage with squared Euclidean distance as a measure of 
distance (x-axis values). HCA resulted in the formation of clusters that were iteratively joined in a 
descending order of similarity. Resulting dendrograms show different patterns of neuroanatomical changes 
in patients with OSA following interventions with BSC alone (N=27) from those resulting post CPAP with 
BSC (N=28) treatment. The HCA findings also suggest that the thalamic alterations (arrows) in the CPAP 
group are closely linked to a wider core neurocircuitry adaptations (pink boxes).   
 
Figure 3: Significant structural change in OSA patients Pre and Post CPAP treatment.  
The first row (Pre-) shows neuroanatomical structures that were noted as hypotrophic in OSA patients (N= 
55) before any intervention, by comparison to matched healthy volunteers (N=35); bilateral globus pallidi, 
left hippocampi and mid posterior section of corpus callosum. The second row (Post-) depicts hypertrophic 
changes noted in bilateral thalami following one month of treatment with CPAP; the longitudinal structural 
changes were calculated by normalization to the individual baseline volumes (refer to the equation).  
 
Figure 4: Neuroplastic structural changes following one month of intervention with the Continuous 
Positive Airway Pressure or Best Supportive Care treatment.  
Potential strengthening in interregional connectivity between the non-dominant thalamus with hippocampus 
and (or) cerebellar cortex in OSA patients was noted only in CPAP treated group (first row). In addition, in 
the same group of patients, improvement in sleepiness (as shown by the ESS), was strongly positively 
correlated to changes occurring in brainstem during this period (second row). 
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Figure 5: Schematic presentation of the neuroarchitecture behind working memory maintenance 
processes that might be implicated in improved daytime somnolence and verbal episodic memory 
by the CPAP treatment. Distributed nature of processes and representations involved to solve working-
memory tasks is shown52, 54, with thalamus (central structure) acting as a functional interface between 
arousal and attentional regulation.51  The hippocampus (elongated green), is the structure most frequently 
reported affected by neuroimaging in OSA,3, 33, here it is proposed to bind aspects of working and episodic 
memory.54, 56 The list of cognitive tests used in our study to investigate impact of CPAP treatment on 
associated cognitive domains is also depicted. CPAP treatment leads to improvement in verbal episodic 
memory (green box), which may be due to the interplay of the cascade of gradual changes in the semantic 
and verbal working memory. In addition, CPAP leads to the improvement of excessive daytime somnolence 
(yellow box), which in turn appears to be significantly, correlated to ensuing brainstem alterations. Our 
results also suggest that comparable subjective sleepiness has significantly less impact on the attention 
and maintenance of working memory capacity in patients treated with CPAP.  Abbreviations: CPAP: 
continuous positive airway pressure; BSC: best supportive care; LTM: long term memory; ESS: Epworth 
Sleepiness Scale. 
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Table 1: Baseline characteristics of participants. 
  
Controls 
 
CPAPbaseline  
 
BSCbaseline  
 
Pa CPAPbaseline P
a 
BSCbaseline P
a
baseline 
Age (years) 43·5 (2·1) 48·6 (1·9) 46·5 (2·2) 0·089 0·324 0·503 
BMI (kg/m2) 27·8 (0·6) 34·7 (1·2) 34·1 (1·3)  <0·001 <0·001 0·707 
Education (years) 15·0 (0·4) 14·8 (0·5) 14·5 (0·5) 0·720 0·495 0·755 
AHI (events/h) n/a 36·6 (5·1) 36·4 (4·0) n/a n/a 0·979 
ODI (events /h) 2·3 (0·2) 35·4 (5·1) 37·8 (4·5) <0·001  <0·001  0·655  
ESS 6·2 (0·5) 13·1 (1·0) 12·4 (0·9) <0·001 <0·001 0·548 
Gender (male): n (%)* 28 (80·0%) 28 (100·0%) 24 (88·9%) 0·014 0·491 0·111 
Dexterity (right-handed): n (%) 35 (100·0%) 28 (100·0%) 27 (100·0%) n/a n/a n/a 
 
Data presented as mean (SEM) or number of patients N (%). Abbreviations: Controls: healthy volunteers (N=35); BSC: baseline values for patients treated with best supportive care (BSC) 
(N=27); CPAP: baseline values for patients treated with continuous positive airway pressure (CPAP) with BSC (N=28); BMI: Body mass index, AHI: apopnea/hypopnea index. ODI: oxygen 
desaturation index. P columns: P CPAPbaseline= baseline CPAP with BSC group vs controls P BSCbaseline= baseline BSC vs controls; P= baseline CPAP vs BSc scores. 
a
Bonferroni corrected 
P values. *Fisher exact test. 
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Table 2: Changes in neurocognitive function. 
Cognitive Tests Controls OSAbaseline BSCbaseline CPAPbaseline BSC1month CPAP1month P
a
 
P
a 
BSC1month 
P
a
CPAP1month 
immediate LM 47·06 (1·84) 36·36 (1·32) 37·59 (1·91) 35·17 (1·84) 41·70 (2·28) 44·43 ( 1·99) <0·001* 0·070 0·338 
delayed LM 29·79 (1·37) 22·25 (0·97) 23·41 (1·45) 21·14 (1·28) 27·33 (1·55) 29·93 (1·42) <0·001* 0·238 0·946 
ACE-R  94·91 (0·99) 90·55 (1·11) 88·59 (2·01) 92·42 (0·88) 90·70 (1·85) 91·86 (2·44) 0·008* 0·038 0·220 
Memory  24·18 (0·41) 22·05 (0·57) 21·15 (0·87) 22·92 (0·70) 23·07 (0·65) 23·79 (0·37) 0·009* 0·143 0·493 
Fluency  12·50 (0·3) 11·25 (0·3) 11·22 (0·43) 11·28 (0·42) 11·41 (0·49) 11·89 (0·45) 0·006* 0·050 0·248 
Language  24·12 (0·71) 24·18 (0·37) 23·56 (0·68) 24·78 (0·28) 23·63 (0·68) 25·11 (0·24) 0·930 0·628 0·230 
SSF  9·00 (0·31) 8·33 (0·23) 8·22 (0·31) 8·42 (0·33) 7·93 (0·38) 8·18 (0·4) 0·079 0·032 0·104 
SSB  8·65 (0·26) 7·65 (0·24) 7·52 (0·39) 7·79 (0·29) 7·37 (0·39) 8·18 (0·31) 0·009* 0·007* 0·250 
DSF  12·06 (0·33) 10·22 (0·31) 10·26 (0·45) 10·18 (0·43) 10·70 (0·4) 10·32 (0·51) <0·001* 0·011* 0·005* 
DSB  8·18 (0·39) 6·73 (0·31) 6·93 (0·45) 6·54 (0·42) 7·41 (0·47) 7·26 (0·52) 0·005* 0·210 0·157 
TMA  24·12 (1·18) 27·34 (1·04) 29·19 (1·49) 25·56 (1·38) 28·02 (1·56) 24·26 (1·28) 0·049 0·047 0·937 
TMB  41·23 (2·0) 62·02 (3·65) 69·76 (6·33) 54·56 (3·31) 61·53 (4·81) 51·05 (3·68) <0·001* <0·001* 0·017* 
ESS  6·18 (0·49) 12·80 (0·67) 12·44 (0·88) 13·14 (1·01) 12·11 (0·93) 8·18 (0·85) <0·001* <0·001* 0·038 
 
 
Data presented as mean (SEM). Memory, fluency and language test scores were calculated from respective subtest scores of the  Addenbrooke’s Cognitive Examination-Revised (ACE-R) 
test. Normality was checked using the Kolmogorov-Smirnov test. The plots were normally distributed so independent sample t-test statistics were used to compare patient groups and 
controls. P columns: P= baseline OSA scores vs controls; P BSC= BSC vs controls; P CPAP= CPAP with BSC group vs controls. 
a
Bonferroni corrected P values. 
Abbreviations: Controls: baseline values for healthy volunteers (N=35). OSA: baseline values for all obstructive sleep apnea (OSA) patients before any intervention (N=55); BSC: patients 
treated with best supportive care (BSC) for one month (N=27); CPAP: patients treated with continuous positive airway pressure (CPAP) with BSC for one month (N=28). ESS: Epworth 
sleepiness scale. TMB: Trail Making Test B ;TMA: Trail Making Test A; DSF: Digit-span Forward Task; DSB: Digit-Span Backward Task; SSF: Spatial-span Forward Test; SSB: Spatial-span 
Backward Test; ACE-R: Addenbrooke’s Cognitive Examination- Revised ; LM: logical memory test. 
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Figure 1: CONSORT DIAGRAM 
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34 were allocated to CPAP plus BSC 
All patients received intervention 
 
6 did not undergo full battery of tests 
 
Follow-up complete (N=28) 
7 did not undergo full battery of tests 
 
Follow-up complete (N=27) 
34 were allocated to BSC 
All patients received intervention 
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Figure 5 
 
 
